SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Raises ResMed Price Target to $288 From $262, Maintains Outperform

RBC raised its price target on ResMed to $288 from $262 and maintained its Outperform rating.

RMD

Related stories